Animal models in nonalcoholic steatohepatitis research: utility and clinical translation
These GLP-1RA drugs can improve blood glucose levels and reduce body weight (14, 35)
Association of genetic variants related to gluteofemoral vs abdominal fat distribution with type 2 diabetes, coronary disease, and cardiovascular risk factors
In that time, she has exceeded her weight-loss goal, shedding about 75 pounds from her starting weight of 200
Who Should Choose Tirzepatide: Ideal Candidates: Need maximum weight loss (50+ pounds) Want most effective medication available Can afford $349-$1,069/month depending on option Have BMI 30 (or 27 with comorbidities) Plateaued on semaglutide or other medications No contraindications to GLP-1/GIP agonists Particularly Good For: Significant obesity (BMI 35) Previous weight loss medication failures Those who want best possible results Patients who tolerate GLP-1s well Cost Comparison: Value Analysis: Cost per % Body Weight Lost: Brand-Name Tirzepatide: 22.5% loss at $12,828/year Cost per %: $570 Compounded Tirzepatide (TrimRx): 22.5% loss at $4,188/year Cost per %: $186 Compounded Semaglutide (TrimRx): 14.9% loss at $2,388/year Cost per %: $160 Both compounded options offer excellent value, with semaglutide being slightly more cost-efficient per percentage lost, while tirzepatide produces greater absolute weight loss
/assets/production/practices/faa8d186ce8181d586706ca420b6720efea8382e/images/2701212.png)
